All Comments by Benjamin Wolozin

  1. Angiotensin-Converting Enzyme Inhibitors and Amyotrophic Lateral Sclerosis Risk: A Total Population-Based Case-Control Study.
  2. Therapeutic modulation of eIF2α phosphorylation rescues TDP-43 toxicity in amyotrophic lateral sclerosis disease models.
  3. Suppression of eIF2α kinases alleviates Alzheimer's disease-related plasticity and memory deficits.
  4. Larry Sparks, of Alzheimer’s-Cholesterol Fame, Dies at 63
  5. β-amyloid inhibits protein prenylation and induces cholesterol sequestration by impairing SREBP-2 cleavage.
  6. A "two-hit" hypothesis for inclusion formation by carboxyl-terminal fragments of TDP-43 protein linked to RNA depletion and impaired microtubule-dependent transport.
  7. Phosphorylation-dependent 14-3-3 binding to LRRK2 is impaired by common mutations of familial Parkinson's disease.
  8. A neurodegenerative disease mutation that accelerates the clearance of apoptotic cells.
  9. Law and Disorder—APPswe Patent Suits Raise Ruckus Again
  10. Synergistic Interactions between Abeta, tau, and alpha-synuclein: acceleration of neuropathology and cognitive decline.
  11. Mutant LRRK2(R1441G) BAC transgenic mice recapitulate cardinal features of Parkinson's disease.
  12. A Tribute to Robert Katzman
  13. Use of statins and incidence of dementia and cognitive impairment without dementia in a cohort study.
  14. Trial Troika—Immunotherapy Interrupted, Lipitor Lags, Dimebon Delivers
  15. Statins, incident Alzheimer disease, change in cognitive function, and neuropathology.